Abstract
There is a steady increase in the incidence of pulmonary pathology annually in the Russian Federation, the main nosological entities are bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD). Changes in approaches to diagnosis and treatment, the impact of the COVID-19 pandemic — all of this may have affected the level of BA and COPD primary morbidity over the past decade. Objective. To study the features of the dynamics of primary incidence rates of BA and COPD in the Russian Federation and in Moscow in the period from 2010 to 2019 and during the COVID-19 pandemic. Material and methods. The estimation and analysis of the long-term dynamics of primary incidence of BA and COPD per 100 thousand population in the Russian Federation and Moscow in the period from 2010 to 2022 was carried out according to Rosstat (Federal State Statistics Service) data. Results. There has been an increase in the primary incidence of BA and COPD in the Russian Federation and Moscow in the period from 2010 to 2019. The average annual rate of increase in primary incidence of BA in Russia was +2.19%, in Moscow +0.55%, the rate of increase in primary incidence of COPD in Russia was +1.86%. There was a marked decline in the incidence of BA and COPD during the COVID-19 pandemic in the Russian Federation, with actual incidence rates below predictive levels. There was a sharp drop in the primary incidence of BA in 1.6 times in Moscow in 2020 with a gradual increase by 2022. The incidence of COPD in Moscow in 2022 was 38.7% lower than predicted. Conclusion. There has been an increase in the primary incidence of bronchial asthma and chronic obstructive pulmonary disease in the Russian Federation and Moscow in the period from 2010 to 2019. A significant decrease in the incidence rates of this pathology relative to predictive values has been identified during the COVID-19 pandemic, which means that more in-depth epidemiological studies are needed.

This publication has 20 references indexed in Scilit: